Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph D Spahn

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Allergy and Clinical Immunology|February 18, 2010
Predictors of remitting, periodic, and persistent childhood asthmaRonina A Covar, Robert Strunk, Robert S Zeiger, et al.
Clinical and Experimental Immunology|September 8, 2025
Thymic stromal lymphopoietin as a therapeutic target in patients with chronic rhinosinusitis and nasal polypsAnju T Peters, Joseph K Han, Enrico Heffler, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2014
Eczema and race as combined determinants for differential response to step-up asthma therapyJonathan Malka, David T Mauger, Ronina Covar, et al.
Advances in Therapy|November 8, 2024
Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal PolypsJoshua S Jacobs, Joseph K Han, Jason K Lee, et al.
Advances in Therapy|February 19, 2025
Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal PolypsAnju Peters, Xiaohui Zhao, Aimee M Near, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 24, 2023
Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR)Ian D Pavord, Flavia C L Hoyte, Andrew W Lindsley, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2005
Characterization of within-subject responses to fluticasone and montelukast in childhood asthmaStanley J Szefler, Brenda R Phillips, Fernando D Martinez, et al.
The Journal of Allergy and Clinical Immunology|January 3, 2006
Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthmaRobert S Zeiger, Stanley J Szefler, Brenda R Phillips, et al.
The New England Journal of Medicine|March 4, 2010
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroidsRobert F Lemanske, David T Mauger, Christine A Sorkness, et al.
Controlled Clinical Trials|May 26, 2004
The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education networkTheresa W Guilbert, Wayne J Morgan, Marzena Krawiec, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|February 18, 2010
Predictors of remitting, periodic, and persistent childhood asthmaRonina A Covar, Robert Strunk, Robert S Zeiger, et al.
Clinical and Experimental Immunology|September 8, 2025
Thymic stromal lymphopoietin as a therapeutic target in patients with chronic rhinosinusitis and nasal polypsAnju T Peters, Joseph K Han, Enrico Heffler, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2014
Eczema and race as combined determinants for differential response to step-up asthma therapyJonathan Malka, David T Mauger, Ronina Covar, et al.
Advances in Therapy|November 8, 2024
Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal PolypsJoshua S Jacobs, Joseph K Han, Jason K Lee, et al.
Advances in Therapy|February 19, 2025
Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal PolypsAnju Peters, Xiaohui Zhao, Aimee M Near, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 24, 2023
Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR)Ian D Pavord, Flavia C L Hoyte, Andrew W Lindsley, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2005
Characterization of within-subject responses to fluticasone and montelukast in childhood asthmaStanley J Szefler, Brenda R Phillips, Fernando D Martinez, et al.
The Journal of Allergy and Clinical Immunology|January 3, 2006
Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthmaRobert S Zeiger, Stanley J Szefler, Brenda R Phillips, et al.
The New England Journal of Medicine|March 4, 2010
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroidsRobert F Lemanske, David T Mauger, Christine A Sorkness, et al.
Controlled Clinical Trials|May 26, 2004
The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education networkTheresa W Guilbert, Wayne J Morgan, Marzena Krawiec, et al.
Pageof 6